Augmedix

Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. It offers live support including referrals, orders, and reminders that allow clinicians to focus on patient care. The company was founded by Ian Shakil in 2012 and is headquartered in San Francisco, CA.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Augmedix reports record Q4 earnings, eyes growth in healthcare tech

Augmedix demonstrated robust performance in Q4 2022 with strong revenue growth and bookings.
The company's strategic focus on product development and expansion into new markets bodes well for future growth.
While facing challenges in expenses and competition, Augmedix's opportunities for growth are significant.
Investors can be optimistic about Augmedix's outlook given its solid financial performance and growth prospects.

Augmedix reports robust Q1 growth, eyes profitability amid rising expenses

Augmedix demonstrated strong revenue growth, customer retention, and cost management in Q1 2023.
While facing challenges such as increasing expenses and cash outflows, the company remains focused on achieving profitability.
With a solid financial position and growth opportunities ahead, Augmedix is poised for continued success in the healthcare technology sector.

Augmedix reports robust Q2 growth, raises revenue guidance for 2023

Augmedix's Q2 performance reflects strong revenue growth, margin expansion, and strategic partnerships driving market positioning. While facing challenges in managing expenses and achieving profitability, the company remains optimistic about its growth trajectory. Augmedix's focus on innovation and capacity expansion positions it well to capitalize on opportunities for sustained revenue growth and market competitiveness.

Augmedix reports strong Q3 earnings, introduces AI app for clinicians

Augmedix demonstrated robust financial growth and operational improvements in Q3 2023, positioning itself for continued success.
The company's innovative product offerings and strategic partnerships underscore its commitment to driving healthcare efficiency.
While facing challenges such as product adoption ramp-up and regulatory compliance, Augmedix remains focused on growth and innovation.

Augmedix reports robust Q4 earnings, eyes growth in healthcare tech

Augmedix's strong financial performance in Q4 2023 reflects revenue growth, improved EBITDA, and strategic cost management, positioning the company for future success.
Diverse product offerings, positive partnerships, and efficient capital deployment are key strengths driving Augmedix's growth trajectory and market competitiveness.
While facing profitability challenges and the need for revenue diversification, Augmedix has significant opportunities in the expanding healthcare technology market and strong market demand for its products.

Augmedix reports robust Q1 growth, eyes AI-first SaaS transition

Augmedix's Q1 performance reflects strong revenue growth and strategic product launches, despite challenges in revenue outlook and increased expenses.
The company's focus on transitioning to an AI-first SaaS model and leveraging partnerships like HCA Healthcare positions it for future growth.
Optimism about clinical adoption and a commitment to reaching cash flow breakeven by 2025 highlight Augmedix's long-term strategic vision.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SAN FRANCISCO, May 12, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three months ended March 31, 2023.

Augmedix Delivers Continued Sales Momentum; Reports First Quarter 2023 Financial Results

Garmin

QuickLogic

Wearables are becoming very popular because many consumers are using them to monitor their progress during exercise and to track their health. Deloitte has estimated that the sales of wearable devices for the medical sector will jump to 440 million devices next year from 275 million devices in 2021.

3 Must-Watch Wearable Tech Stocks as the Industry Booms

SAN FRANCISCO, April 20, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading ambient medical documentation, today announced a partnership with HCA Healthcare, Inc. (NYSE: HCA), one of the nation's leading healthcare providers, to accelerate development of technology that aims to transform the way patient care is documented in the acute care setting.

Augmedix Announces Partnership with HCA Healthcare to Accelerate the Development of AI-enabled Ambient Documentation

Company raises $12 million of new equity from HCA Healthcare and Redmile Group; Augmedix and HCA Healthcare to collaborate on AI-powered ambient documentation products for the acute care setting; Provides sufficient capital to achieve cash flow sustainability

Augmedix Secures Strategic Financing from HCA Healthcare and Redmile Group

Augmedix, Inc. (NASDAQ:AUGX ) Q4 2022 Earnings Conference Call March 27, 2023 8:00 AM ET Company Participants Matt Chesler - Investor Relations Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Jared Hasson - William Blair Neil Chatterji - B. Riley Securities Allen Klee - Maxim Group Operator Greetings, welcome to Augmedix Incorporated 2022 Fourth Quarter Earnings Conference Call.

Augmedix, Inc. (AUGX) Q4 2022 Earnings Call Transcript

SAN FRANCISCO, March 27, 2023 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leading provider of ambient medical documentation and data solutions delivered remotely to healthcare systems, physician practices, hospitals, and telemedicine practitioners, today reported financial results for the three and 12 months ended December 31, 2022.

Augmedix Reports Strong Commercial Traction and Sales Momentum; Reports Fourth Quarter and Full Year 2022 Financial Results

Company also announces participation in the ViVE Conference in Nashville, TN, on March 27-28, 2023 Company also announces participation in the ViVE Conference in Nashville, TN, on March 27-28, 2023

Augmedix to Announce Fourth Quarter and Full-Year 2022 Financial Results and Host Conference Call on March 27, 2023

SAN FRANCISCO, March 07, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that Manny Krakaris, Chief Executive Officer, and Paul Ginocchio, Chief Financial Officer will attend and present at the Oppenheimer 33rd Annual Healthcare Conference taking place virtually on March 13 – 15, 2023.

Augmedix Announces Participation in Oppenheimer's 33rd Annual Healthcare Conference

SAN FRANCISCO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Augmedix Inc. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that its leadership team will participate in the Maxim Group Virtual Healthcare IT Conference on Wednesday, January 25, 2023. Manny Krakaris, Chief Executive Officer, will join the “Doctors Panel” which will be webcast live at 12:30 p.m. ET. Mr. Krakaris and Paul Ginocchio, Chief Financial Officer, will also host investor meetings throughout the day.

Augmedix Announces Participation in Maxim Group Healthcare IT Investor Conference on January 25

SAN FRANCISCO, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Augmedix In c. (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced the Company will participate in Benchmark Company's 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1, 2022 at the New York Athletic Club in New York City. Augmedix's management will participate in one-on-one meetings with institutional analysts and investors throughout the day.

Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference

Partnership aims to positively impact veterinarians through implementing automated medical documentation and live clinical support Partnership aims to positively impact veterinarians through implementing automated medical documentation and live clinical support

Augmedix Announces Partnership with Veterinary Specialty Center to Support Emergency Veterinary and Specialty Care

Augmedix, Inc. (NASDAQ:AUGX ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Ji-Yon Yi - Gilmartin Group LLC Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Marc Wiesenberger - B. Riley Securities Charlie Montang - Lake Street Capital Markets, LLC Allen Klee - Maxim Group Operator Greetings and welcome to Augmedix, Inc. Third Quarter 2022 Earnings Call.

Augmedix, Inc. (AUGX) Q3 2022 Earnings Call Transcript

SAN FRANCISCO, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today reported financial results for the three months ended September 30, 2022.

Augmedix Reports Third Quarter 2022 Financial Results

The new partnership empowers Kirby providers to focus more on point-of-care conversations with Augmedix's automated medical documentation and live clinical support The new partnership empowers Kirby providers to focus more on point-of-care conversations with Augmedix's automated medical documentation and live clinical support

Augmedix Partners with Kirby Medical Center to Significantly Reduce Documentation Burden for Physicians and Improve Patient Experiences

SAN FRANCISCO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming Lytham Partners Fall Investor Conference.

Augmedix to Participate at the 2022 Lytham Partners Fall Investor Conference

Allows Physicians to Spend Less Time in the EHR and More Time with Patients Allows Physicians to Spend Less Time in the EHR and More Time with Patients

Augmedix Launches New Service, Augmedix Prep, to Significantly Reduce Physician Chart Prep Burden

SAN FRANCISCO, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming hybrid H.C. Wainwright 24th Annual Global Investment Conference, to be held virtually and in-person in New York.

Augmedix to Present at the H.C. Wainwright 24th Annual Global Investment Conference

SAN FRANCISCO, Aug. 17, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at 10:50 a.m. ET.

Augmedix to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

Augmedix, Inc. (NASDAQ:AUGX ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Caroline Paul - Investor Relations Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Marc Wiesenberger - B. Riley Securities Allen Klee - Maxim Group Brooks O'Neil - Lake Street Capital Markets Operator Hello, and welcome to the Augmedix, Inc. Second Quarter 2022 Earnings Call.

Augmedix, Inc. (AUGX) CEO Manny Krakaris on Q2 2022 Results - Earnings Call Transcript

Partnership Takes an Innovative Approach to Address Physician Well-Being

Augmedix Announces Expanded Partnership with Adventist Health

SAN FRANCISCO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Today, Trio Health (Trio) and Augmedix (Nasdaq: AUGX), in partnership with the Consortium of Independent Immunology Clinics (CIIC), announced the launch of an innovative platform to automate, standardize, and structure clinical patient data, right from the point of care. The Trio, Augmedix and CIIC physicians' real-world patient ecosystem deliver research-ready clinical insights and real-time disease surveillance for allergy, asthma and immunology care.

Augmedix - Trio Health - CIIC First of its Kind Real-World Patient Ecosystem - Standardizing Relevant Clinical Data at the Point of Care

SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced it will report financial results for the second quarter of 2022 on Monday, August 8, 2022, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Augmedix to Report Second Quarter 2022 Financial Results on August 8, 2022

SAN FRANCISCO, May 26, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today announced the company will be participating in the upcoming William Blair Growth Stock Conference in Chicago.

Augmedix to Present at the William Blair 42nd Annual Growth Stock Conference

Augmedix, Inc. (NASDAQ:AUGX ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Caroline Paul - Investor Relations Manny Krakaris - Chief Executive Officer and Board Member Paul Ginocchio - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Marc Wiesenberger - B Riley FBR Brooks O'Neil - Lake Street Capital Markets Allen Klee - Maxim Group Operator Hello and welcome to the Augmedix, Inc. 2022 First Quarter Earnings Conference Call. All participants will be in listen-only mode.

Augmedix, Inc. (AUGX) CEO Manny Krakaris on Q1 2022 Results - Earnings Call Transcript

SAN FRANCISCO, May 09, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of automated medical documentation and data services, today reported financial results for the three months ended March 31, 2022.

News for Augmedix Stock (AUGX)